Safety and Potency of a High Cabergoline Dosage in Microprolactinomas

Recruiting

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(16 sites)

Brazil

UFMG, Belo Horizonte

Unesp, Botucatu

UNB, Brasília

Unicamp, Campinas

UFPR, Curitiba

UFG, Goiânia

CPC, Ponta Grossa

HCPA, Porto Alegre

Hospital Moinhos de Vento, Porto Alegre

Sta Casa-RS, Porto Alegre

UFPE, Recife

USP-RP, Ribeirão Preto

UFRJ, Rio de Janeiro

HCFMUSP, São Paulo

Sta Casa-SP, São Paulo

Unifesp, São Paulo